Literature DB >> 33750785

Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma.

Lanqi Gong1,2, Dora Lai-Wan Kwong1,2, Wei Dai1,2, Pingan Wu3, Shanshan Li1, Qian Yan1,2, Yu Zhang2, Baifeng Zhang2, Xiaona Fang2, Li Liu4,5,6, Min Luo1, Beilei Liu2, Larry Ka-Yue Chow2, Qingyun Chen7, Jinlin Huang2, Victor Ho-Fun Lee1,2, Ka-On Lam1,2, Anthony Wing-Ip Lo8, Zhiwei Chen4,5,6, Yan Wang9, Anne Wing-Mui Lee1,2, Xin-Yuan Guan10,11,12.   

Abstract

The tumor microenvironment (TME) of nasopharyngeal carcinoma (NPC) harbors a heterogeneous and dynamic stromal population. A comprehensive understanding of this tumor-specific ecosystem is necessary to enhance cancer diagnosis, therapeutics, and prognosis. However, recent advances based on bulk RNA sequencing remain insufficient to construct an in-depth landscape of infiltrating stromal cells in NPC. Here we apply single-cell RNA sequencing to 66,627 cells from 14 patients, integrated with clonotype identification on T and B cells. We identify and characterize five major stromal clusters and 36 distinct subpopulations based on genetic profiling. By comparing with the infiltrating cells in the non-malignant microenvironment, we report highly representative features in the TME, including phenotypic abundance, genetic alternations, immune dynamics, clonal expansion, developmental trajectory, and molecular interactions that profoundly influence patient prognosis and therapeutic outcome. The key findings are further independently validated in two single-cell RNA sequencing cohorts and two bulk RNA-sequencing cohorts. In the present study, we reveal the correlation between NPC-specific characteristics and progression-free survival. Together, these data facilitate the understanding of the stromal landscape and immune dynamics in NPC patients and provides deeper insights into the development of prognostic biomarkers and therapeutic targets in the TME.

Entities:  

Mesh:

Year:  2021        PMID: 33750785      PMCID: PMC7943808          DOI: 10.1038/s41467-021-21795-z

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  50 in total

1.  Comprehensive Integration of Single-Cell Data.

Authors:  Tim Stuart; Andrew Butler; Paul Hoffman; Christoph Hafemeister; Efthymia Papalexi; William M Mauck; Yuhan Hao; Marlon Stoeckius; Peter Smibert; Rahul Satija
Journal:  Cell       Date:  2019-06-06       Impact factor: 41.582

2.  A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.

Authors:  Anne W M Lee; Stewart Y Tung; Wai Tong Ng; Victor Lee; Roger K C Ngan; Horace C W Choi; Lucy L K Chan; Lillian L Siu; Alice W Y Ng; To Wai Leung; Harry H Y Yiu; Brian O'Sullivan; Rick Chappell
Journal:  Cancer       Date:  2017-06-29       Impact factor: 6.860

3.  Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma.

Authors:  Juan Lu; Xiao-Mei Chen; Hao-Ran Huang; Fei-Peng Zhao; Fan Wang; Xiong Liu; Xiang-Ping Li
Journal:  Head Neck       Date:  2018-03-01       Impact factor: 3.147

Review 4.  Role of tumor-associated macrophages in tumor progression and invasion.

Authors:  Alberto Mantovani; Tiziana Schioppa; Chiara Porta; Paola Allavena; Antonio Sica
Journal:  Cancer Metastasis Rev       Date:  2006-09       Impact factor: 9.264

5.  COX-2 promotes metastasis in nasopharyngeal carcinoma by mediating interactions between cancer cells and myeloid-derived suppressor cells.

Authors:  Ze-Lei Li; Shu-Biao Ye; Li-Yin OuYang; Han Zhang; Yu-Shan Chen; Jia He; Qiu-Yan Chen; Chao-Nan Qian; Xiao-Shi Zhang; Jun Cui; Yi-Xin Zeng; Jiang Li
Journal:  Oncoimmunology       Date:  2015-07-09       Impact factor: 8.110

6.  T cell therapy for nasopharyngeal carcinoma.

Authors:  S Basso; M Zecca; P Merli; A Gurrado; S Secondino; G Quartuccio; I Guido; P Guerini; G Ottonello; N Zavras; R Maccario; P Pedrazzoli; P Comoli
Journal:  J Cancer       Date:  2011-06-03       Impact factor: 4.207

7.  Single-cell mRNA quantification and differential analysis with Census.

Authors:  Xiaojie Qiu; Andrew Hill; Jonathan Packer; Dejun Lin; Yi-An Ma; Cole Trapnell
Journal:  Nat Methods       Date:  2017-01-23       Impact factor: 28.547

8.  TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion.

Authors:  Omar Khan; Josephine R Giles; Sierra McDonald; Sasikanth Manne; Shin Foong Ngiow; Kunal P Patel; Michael T Werner; Alexander C Huang; Katherine A Alexander; Jennifer E Wu; John Attanasio; Patrick Yan; Sangeeth M George; Bertram Bengsch; Ryan P Staupe; Greg Donahue; Wei Xu; Ravi K Amaravadi; Xiaowei Xu; Giorgos C Karakousis; Tara C Mitchell; Lynn M Schuchter; Jonathan Kaye; Shelley L Berger; E John Wherry
Journal:  Nature       Date:  2019-06-17       Impact factor: 49.962

Review 9.  Emerging treatment options for nasopharyngeal carcinoma.

Authors:  Lu Zhang; Qiu-Yan Chen; Huai Liu; Lin-Quan Tang; Hai-Qiang Mai
Journal:  Drug Des Devel Ther       Date:  2013-02-01       Impact factor: 4.162

10.  B cells and tertiary lymphoid structures promote immunotherapy response.

Authors:  Beth A Helmink; Sangeetha M Reddy; Jianjun Gao; Shaojun Zhang; Rafet Basar; Rohit Thakur; Keren Yizhak; Moshe Sade-Feldman; Jorge Blando; Guangchun Han; Vancheswaran Gopalakrishnan; Yuanxin Xi; Hao Zhao; Rodabe N Amaria; Hussein A Tawbi; Alex P Cogdill; Wenbin Liu; Valerie S LeBleu; Fernanda G Kugeratski; Sapna Patel; Michael A Davies; Patrick Hwu; Jeffrey E Lee; Jeffrey E Gershenwald; Anthony Lucci; Reetakshi Arora; Scott Woodman; Emily Z Keung; Pierre-Olivier Gaudreau; Alexandre Reuben; Christine N Spencer; Elizabeth M Burton; Lauren E Haydu; Alexander J Lazar; Roberta Zapassodi; Courtney W Hudgens; Deborah A Ledesma; SuFey Ong; Michael Bailey; Sarah Warren; Disha Rao; Oscar Krijgsman; Elisa A Rozeman; Daniel Peeper; Christian U Blank; Ton N Schumacher; Lisa H Butterfield; Monika A Zelazowska; Kevin M McBride; Raghu Kalluri; James Allison; Florent Petitprez; Wolf Herman Fridman; Catherine Sautès-Fridman; Nir Hacohen; Katayoun Rezvani; Padmanee Sharma; Michael T Tetzlaff; Linghua Wang; Jennifer A Wargo
Journal:  Nature       Date:  2020-01-15       Impact factor: 69.504

View more
  18 in total

1.  GLIPR1 promotes proliferation, metastasis and 5-fluorouracil resistance in hepatocellular carcinoma by activating the PI3K/PDK1/ROCK1 pathway.

Authors:  Yuen Chak Tiu; Lanqi Gong; Yu Zhang; Jie Luo; Yuma Yang; Ying Tang; Wing-Mui Lee; Xin-Yuan Guan
Journal:  Cancer Gene Ther       Date:  2022-06-27       Impact factor: 5.987

Review 2.  Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors.

Authors:  Liangliang Xu; Chang Zou; Shanshan Zhang; Timothy Shun Man Chu; Yan Zhang; Weiwei Chen; Caining Zhao; Li Yang; Zhiyuan Xu; Shaowei Dong; Hao Yu; Bo Li; Xinyuan Guan; Yuzhu Hou; Feng-Ming Kong
Journal:  J Hematol Oncol       Date:  2022-07-07       Impact factor: 23.168

Review 3.  Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities.

Authors:  Céline M Laumont; Allyson C Banville; Mara Gilardi; Daniel P Hollern; Brad H Nelson
Journal:  Nat Rev Cancer       Date:  2022-04-07       Impact factor: 69.800

4.  Intercellular Communication-Related Molecular Subtypes and a Gene Signature Identified by the Single-Cell RNA Sequencing Combined with a Transcriptomic Analysis.

Authors:  Pin Guan; Wentao Cai; Ke Wu; Fan Jiang; Jinchan Wu; Xin Zhai; Min Zeng
Journal:  Dis Markers       Date:  2022-05-16       Impact factor: 3.464

5.  JUPITER-02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps.

Authors:  Laura Ling Ying Tan; Quynh-Thu Le; Nancy Ying Ying Lee; Melvin Lee Kiang Chua
Journal:  Cancer Commun (Lond)       Date:  2021-12-16

6.  Dissecting the heterogeneity of the microenvironment in primary and recurrent nasopharyngeal carcinomas using single-cell RNA sequencing.

Authors:  Wen-Sa Peng; Xin Zhou; Wen-Bin Yan; Yu-Jiao Li; Cheng-Run Du; Xiao-Shen Wang; Chun-Ying Shen; Qi-Feng Wang; Hong-Mei Ying; Xue-Guan Lu; Ting-Ting Xu; Chao-Su Hu
Journal:  Oncoimmunology       Date:  2022-01-25       Impact factor: 8.110

7.  Deciphering cell lineage specification of human lung adenocarcinoma with single-cell RNA sequencing.

Authors:  Zhoufeng Wang; Zhe Li; Kun Zhou; Chengdi Wang; Lili Jiang; Li Zhang; Ying Yang; Wenxin Luo; Wenliang Qiao; Gang Wang; Yinyun Ni; Shuiping Dai; Tingting Guo; Guiyi Ji; Minjie Xu; Yiying Liu; Zhixi Su; Guowei Che; Weimin Li
Journal:  Nat Commun       Date:  2021-11-11       Impact factor: 14.919

8.  A single-cell transcriptomic landscape of innate and adaptive intratumoral immunity in triple negative breast cancer during chemo- and immunotherapies.

Authors:  Alessandro Raveane; Francesco Bertolini; Laura Carpen; Paolo Falvo; Stefania Orecchioni; Giulia Mitola; Roman Hillje; Saveria Mazzara; Patrizia Mancuso; Stefano Pileri
Journal:  Cell Death Discov       Date:  2022-03-08

Review 9.  Nasopharyngeal Carcinoma and Its Microenvironment: Past, Current, and Future Perspectives.

Authors:  Zhi Yi Su; Pui Yan Siak; Chee-Onn Leong; Shiau-Chuen Cheah
Journal:  Front Oncol       Date:  2022-03-02       Impact factor: 6.244

Review 10.  Epstein-Barr Virus Epithelial Cancers-A Comprehensive Understanding to Drive Novel Therapies.

Authors:  Shuting Han; Joshua K Tay; Celestine Jia Ling Loh; Axel Jun Ming Chu; Joe Poh Sheng Yeong; Chwee Ming Lim; Han Chong Toh
Journal:  Front Immunol       Date:  2021-12-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.